Comparative Tolerability of Pharmacological Treatments for Patent Ductus Arteriosus
- 1 January 2001
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 24 (7), 537-551
- https://doi.org/10.2165/00002018-200124070-00005
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or lessThe Journal of Pediatrics, 1996
- Low-dose indomethacin therapy and extension of intraventricular hemorrhage: A multicenter randomized trialThe Journal of Pediatrics, 1994
- Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infantsThe Journal of Pediatrics, 1991
- Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosusThe Journal of Pediatrics, 1990
- Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonatesThe Journal of Pediatrics, 1988
- Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosusThe Journal of Pediatrics, 1984
- Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosusThe Journal of Pediatrics, 1983
- Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant eweThe Journal of Pediatrics, 1979
- Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndromeThe Journal of Pediatrics, 1978
- Congestive heart failure from suspected ductal closure in uteroThe Journal of Pediatrics, 1969